Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Getting melanoma cells to stimulate with frequency

William E Carson

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |November 2, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A case report of acute carcinoid heart failure during lutetium-177 dotatate-triapine treatment for well-differentiated neuroendocrine tumors.

    Frontiers in oncology·2026
    Same author

    Acute circulating tumor DNA dynamics during and after systemic therapy initiation for advanced triple-negative breast cancer.

    NPJ breast cancer·2026
    Same author

    Early life abuse and neglect in breast cancer survivors: Associations with physical and psychological health throughout diagnosis and survivorship.

    Journal of traumatic stress·2026
    Same author

    Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.

    Nature cancer·2026
    Same author

    Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance).

    Cancer immunology research·2026
    Same author

    Cancer mortality rates by detailed occupation among US working-age adults between 2020 and 2023: a population-based study.

    The Lancet. Oncology·2025